The primary aim of this study is to compare the effects of the active cycle of breathing technique (ACBT), oscillating positive expiratory pressure (O-PEP) therapy, and walking with huffing on sputum expectoration for adults hospitalised with an acute exacerbation of bronchiectasis. Second- ary ...
Department of Bio-immunical TherapyDianhua WangTumor Hospital of Yunnan ProvinceXuan ZhangYunnan Phamacological Laboratory of Natural ProductsXing Song中德临床肿瘤学杂志:英文版PEPT2 mRNA在肺纤维化大鼠肺组织表达研究(英文)[J]. Li Li,Dianhua Wang,Xuan Zhang,Xing Song.The Chinese-German Journal of ...
Primary outcome was the incidence of COVID-19 cases, definite COVID-19 cases & probable COVID-19 cases. Secondary outcomes were 1.new onset symptoms of COVID-19, 2. Compliance to the advised therapy, 3. Incidence of adverse drug reaction (ADR). ...
1529 men with a history of myocardial infarction (MI) and previously treated with either dextrothyroxine or estrogen therapy in the Coronary Drug Project w... DJ Harris,ML Begleiter,J Overbeek,... - Journal of Chronic Disease 29(10): 625-642. October 1976 被引量: 183发表: 1976年 Seasona...
Conclusions and Relevance Among peanut-allergic children aged 4 to 11 years, the percentage difference in responders at 12 months with the 250-μg peanut-patch therapy vs placebo was 21.7% and was statistically significant, but did not meet the prespecified lower bound of the confidence interval ...
Gonzalez then presses him on the “Global South” and how it doesn’t support Ukraine. He refers to an article by (Shock-Therapy) Jeffrey Sachs. (I’ve criticized himhere.) Talking about Sachs, Gonzalez says “the Ukrainian war is a reflection of that, is a continued insistence of the ...
resistance to ALK inhibition in neuroblastoma [1]. Because BORIS is expressed specifically in carcinomas but not in normal tissues, it can be applied for cancer diagnosis or therapy. Immunizations with DNA encoding a BORIS antigen inhibited growth of mammary carcinomas and prolonged the survival ...
Second-generation compound for the modulation of utrophin in the therapy of DMD This detailed evaluation of the SMT C1100 drug series strongly endorses the therapeutic potential of utrophin modulation as a disease modifying therapeutic strategy for all DMD patients irrespective of their dystrophin mutatio...
with known clinical variables, particularly BRCA1 status, comprising the tissue before and after acquired resistance or relapse (e.g. drug resistant metastatic tissues), to ascertain whether EN1 is a marker involved in acquired resistance beyond the initial sensitivity to therapy in cancer patients....
Without therapy, cases may be self-limited, intermittently recurrent, or chronic. Clinical manifestations In 1983, the International Working Group on Bacterial Vaginosis formulated clinical criteria for the diagnosis of bacterial vaginosis; these are commonly referred to as the Amsel criteria (Table 5.2...